Tenet Healthcare (THC)
(Delayed Data from NYSE)
$151.63 USD
+1.89 (1.26%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $151.64 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$151.63 USD
+1.89 (1.26%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $151.64 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth A Momentum A VGM
Zacks News
Tenet Healthcare (THC) Q1 Earnings Beat Estimates, Down Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) first-quarter earnings gain from strategic operational initiatives.
4 High Earnings Yield Stocks to Strengthen Your Portfolio
by Zacks Equity Research
Earnings yield is handy for comparing the performance of the market with the 10-year Treasury yield.
Tenet Healthcare (THC) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Tenet Healthcare (THC) is likely to be hit by declining revenues in the first quarter of 2019.
WellCare Unit Inks Deal to Serve Medicaid Liver Patients
by Zacks Equity Research
WellCare's (WCG) unit inks a value-based deal to introduce the Hepatitis C Center of Excellence program for check-up and treatment of Medicaid members.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Sector ETFs & Stocks to Shine on Upbeat March Jobs Data
by Sanghamitra Saha
March jobs report beat expectations in the United States. These sectors have added maximum jobs and thus put the following ETFs in focus.
Community Health to Sell Unit for Streamlining Operations
by Zacks Equity Research
Community Health (CYH) to divest 245-bed Tennova Healthcare - Lebanon in Tennessee to focus on its profitable businesses.
Tenet (THC) Up 5.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HCA Healthcare's Organic & Inorganic Strategies Drive Growth
by Zacks Equity Research
A number of acquisitions, network expansion, technological investment and strong balance sheet drive growth at HCA Healthcare (HCA).
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Value Stocks With Impressive PEG Ratio
by Zacks Equity Research
Going by the fundamentals of value investing, while picking undervalued stocks, investors need to focus on their earnings growth potential.
Top Ranked Growth Stocks to Buy for March 18th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 18th
Tenet Healthcare (THC) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 112.50% and 2.87%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Is Tenet Healthcare (THC) a Good Stock for Value Investors?
by Zacks Equity Research
Let's see if Tenet Healthcare Corporation (THC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Here's Why You Should Add Tenet Healthcare to Your Portfolio
by Zacks Equity Research
Riding high on a solid inorganic growth profile and divestitures, Tenet Healthcare (THC) holds ample chances of reaping benefits for investors.
Will Tenet Healthcare Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Tenet Healthcare.
5 Excellent GARP Picks With Discounted PEG
by Zacks Equity Research
Although PEG ratio is categorized under value investing, this strategy follows the principles of both growth and value investing.
Acadia Healthcare (ACHC) Q4 Earnings Miss, Revenues Meet
by Zacks Equity Research
Acadia Healthcare (ACHC) Q4 earnings miss, down year over year on increase in expenses.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Down Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) fourth-quarter results reflect earnings decline due to a decrease in operating revenues.
Tenet Healthcare (THC) Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Tenet Healthcare's (THC) Q4 earnings are likely to suffer lower admissions due to divestitures.
Earnings Preview: Tenet Healthcare (THC) Q4 Earnings Expected to Decline
by Zacks Equity Research
Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Molina Healthcare (MOH) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Molina Healthcare's (MOH) fourth-quarter earnings trump estimates on the back of lower costs and higher premium revenues.
Ensign Group's (ENSG) Q4 Earnings Top Estimates, Surge Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) fourth-quarter earnings rise on the back of solid segmental growth.
MEDNAX (MD) Q4 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Mednax's (MD) Q4 gains on revenue growth. However, the same is partly offset by rise in expenses.
Is a Beat in Store for Molina Healthcare (MOH) Q4 Earnings?
by Zacks Equity Research
Molina Healthcare (MOH) is expected to gain in Q4 on the back of membership strength and its streamlining initiative. However, the same might be partly offset by a dismal Marketplace business.